Table of Contents
Computational Biology Journal
Volume 2015, Article ID 427217, 10 pages
http://dx.doi.org/10.1155/2015/427217
Research Article

Structural Differences in KIR3DL1 and LILRB1 Interaction with HLA-B and the Loading Peptide Polymorphisms: In Silico Evidences

1ProxAgen Ltd., 63 Shipchenski Prohod, 1574 Sofia, Bulgaria
2Department of Biology, University of Rome Tor Vergata, Via della Ricerca Scientifica 18, 00133 Rome, Italy
3Department of Biomedicine and Prevention, University of Rome Tor Vergata, Via Montpellier 1, 00133 Rome, Italy

Received 24 August 2015; Revised 21 October 2015; Accepted 26 October 2015

Academic Editor: Jinn Moon Yang

Copyright © 2015 Alba Grifoni et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. M. Carrington, M. P. Martin, and J. van Bergen, “KIR-HLA intercourse in HIV disease,” Trends in Microbiology, vol. 16, no. 12, pp. 620–627, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. F. R. Guerini and M. Clerici, “NK cells in human disease: an evolving story,” Clinical Immunology, vol. 143, no. 3, pp. 203–206, 2012. View at Publisher · View at Google Scholar · View at Scopus
  3. S. Kulkarni, M. P. Martin, and M. Carrington, “The Yin and Yang of HLA and KIR in human disease,” Seminars in Immunology, vol. 20, no. 6, pp. 343–352, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. F. Marras, F. Bozzano, and A. De Maria, “Involvement of activating NK cell receptors and their modulation in pathogen immunity,” Journal of Biomedicine and Biotechnology, vol. 2011, Article ID 152430, 11 pages, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. P. J. Norman, L. Abi-Rached, K. Gendzekhadze et al., “Unusual selection on the KIR3DL1/S1 natural killer cell receptor in Africans,” Nature Genetics, vol. 39, no. 9, pp. 1092–1099, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. P. Parham, P. J. Norman, L. Abi-Rached, and L. A. Guethlein, “Variable NK cell receptors exemplified by human KIR3DL1/S1,” Journal of Immunology, vol. 187, no. 1, pp. 11–19, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. P. Parham, P. J. Norman, L. Abi-Rached, and L. A. Guethlein, “Human-specific evolution of killer cell immunoglobulin-like receptor recognition of major histocompatibility complex class I molecules,” Philosophical Transactions of the Royal Society B: Biological Sciences, vol. 367, no. 1590, pp. 800–811, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. W. H. Carr, M. J. Pando, and P. Parham, “KIR3DL1 polymorphisms that affect NK cell inhibition by HLA-Bw4 ligand,” Journal of Immunology, vol. 175, no. 8, pp. 5222–5229, 2005. View at Publisher · View at Google Scholar · View at Scopus
  9. G. M. O'Connor, K. J. Guinan, R. T. Cunningham, D. Middleton, P. Parham, and C. M. Gardiner, “Functional polymorphism of the KIR3DL1/S1 receptor on human NK cells,” Journal of Immunology, vol. 178, no. 1, pp. 235–241, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. B. Sanjanwala, M. Draghi, P. J. Norman, L. A. Guethlein, and P. Parham, “Polymorphic sites away from the Bw4 epitope that affect interaction of Bw4+ HLA-B with KIR3DL1,” Journal of Immunology, vol. 181, no. 9, pp. 6293–6300, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. J. P. Vivian, R. C. Duncan, R. Berry et al., “Killer cell immunoglobulin-like receptor 3DL1-mediated recognition of human leukocyte antigen B,” Nature, vol. 479, no. 7373, pp. 401–405, 2011. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Fadda, G. M. O'Connor, S. Kumar et al., “Common HIV-1 peptide variants mediate differential binding of KIR3DL1 to HLA-Bw4 molecules,” Journal of Virology, vol. 85, no. 12, pp. 5970–5974, 2011. View at Publisher · View at Google Scholar · View at Scopus
  13. E. O. Long and S. Rajagopalan, “HLA class I recognition by killer cell Ig-like receptors,” Seminars in Immunology, vol. 12, no. 2, pp. 101–108, 2000. View at Publisher · View at Google Scholar · View at Scopus
  14. G. M. O'Connor, J. P. Vivian, J. M. Widjaja et al., “Mutational and structural analysis of KIR3DL1 reveals a lineage-defining allotypic dimorphism that impacts both HLA and peptide sensitivity,” The Journal of Immunology, vol. 192, no. 6, pp. 2875–2884, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Peruzzi, K. C. Parker, E. O. Long, and M. S. Malnati, “Peptide sequence requirements for the recognition of HLA-B2705 by specific natural killer cells,” The Journal of Immunology, vol. 157, no. 8, pp. 3350–3356, 1996. View at Google Scholar · View at Scopus
  16. P. M. Saunders, J. P. Vivian, N. Baschuk et al., “The Interaction of KIR3DL1001 with HLA class I molecules is dependent upon molecular microarchitecture within the Bw4 epitope,” Journal of Immunology, vol. 194, no. 2, pp. 781–789, 2015. View at Publisher · View at Google Scholar · View at Scopus
  17. G. B. E. Stewart-Jones, K. di Gleria, S. Kollnberger, A. J. McMichael, E. Y. Jones, and P. Bowness, “Crystal structures and KIR3DL1 recognition of three immunodominant viral peptides complexed to HLA-B2705,” European Journal of Immunology, vol. 35, no. 2, pp. 341–351, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Grifoni, C. Montesano, A. Patronov, V. Colizzi, and M. Amicosante, “Immunoinformatic docking approach for the analysis of KIR3DL1/HLA-B interaction,” BioMed Research International, vol. 2013, Article ID 283805, 5 pages, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. M. Colonna, F. Navarro, T. Bellón et al., “A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells,” The Journal of Experimental Medicine, vol. 186, no. 11, pp. 1809–1818, 1997. View at Publisher · View at Google Scholar · View at Scopus
  20. N. T. Young, M. Uhrberg, J. H. Phillips, L. L. Lanier, and P. Parham, “Differential expression of leukocyte receptor complex-encoded Ig-like receptors correlates with the transition from effector to memory CTL,” The Journal of Immunology, vol. 166, no. 6, pp. 3933–3941, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. D. Mavilio, J. Benjamin, M. Daucher et al., “Natural killer cells in HIV-1 infection: dichotomous effects of viremia on inhibitory and activating receptors and their functional correlates,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 25, pp. 15011–15016, 2003. View at Publisher · View at Google Scholar · View at Scopus
  22. Y. Chen, Y. Shi, H. Cheng, Y.-Q. An, and G. F. Gao, “Structural immunology and crystallography help immunologists see the immune system in action: how T and NK cells touch their ligands,” IUBMB Life, vol. 61, no. 6, pp. 579–590, 2009. View at Publisher · View at Google Scholar · View at Scopus
  23. C. S. Clements, L. Kjer-Nielsen, L. Kostenko et al., “Crystal structure of HLA-G: a nonclassical MHC class I molecule expressed at the fetal-maternal interface,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 9, pp. 3360–3365, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. C. S. Clements, L. Kjer-Nielsen, J. McCluskey, and J. Rossjohn, “Structural studies on HLA-G: implications for ligand and receptor binding,” Human Immunology, vol. 68, no. 4, pp. 220–226, 2007. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Colonna and J. Samaridis, “Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells,” Science, vol. 268, no. 5209, pp. 405–408, 1995. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Shiroishi, K. Tsumoto, K. Amano et al., “Human inhibitory receptors Ig-like transcript 2 (ILT2) and ILT4 compete with CD8 for MHC class I binding and bind preferentially to HLA-G,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 15, pp. 8856–8861, 2003. View at Publisher · View at Google Scholar · View at Scopus
  27. T. L. Chapman, A. P. Heikema, and P. J. Bjorkman, “The inhibitory receptor LIR-1 uses a common binding interaction to recognize class I MHC molecules and the viral homolog UL18,” Immunity, vol. 11, no. 5, pp. 603–613, 1999. View at Publisher · View at Google Scholar · View at Scopus
  28. R. L. Allen, T. Raine, A. Haude, J. Trowsdale, and M. J. Wilson, “Cutting edge: Leukocyte receptor complex-encoded immunomodulatory receptors show differing specificity for alternative HLA-B27 structures,” Journal of Immunology, vol. 167, no. 10, pp. 5543–5547, 2001. View at Publisher · View at Google Scholar · View at Scopus
  29. T. Gonen-Gross, H. Achdout, T. I. Arnon et al., “The CD85J/leukocyte inhibitory receptor-1 distinguishes between conformed and β2-microglobulin-free HLA-G molecules,” The Journal of Immunology, vol. 175, no. 8, pp. 4866–4874, 2005. View at Publisher · View at Google Scholar · View at Scopus
  30. D. C. Jones, V. Kosmoliaptsis, R. Apps et al., “HLA class I allelic sequence and conformation regulate leukocyte Ig-like receptor binding,” Journal of Immunology, vol. 186, no. 5, pp. 2990–2997, 2011. View at Publisher · View at Google Scholar · View at Scopus
  31. A. Grifoni, C. Montesano, P. Palma, A. Salerno, V. Colizzi, and M. Amicosante, “Role of HLA-B α-3 domain amino acid position 194 in HIV disease progression,” Molecular Immunology, vol. 53, no. 4, pp. 410–413, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. M. Z. K. A. Aghafar, C. Witt, A. Kamarulzaman et al., “Genetic variations in loci relevant to natural killer cell function are affected by ethnicity but are generally not correlated with susceptibility to HIV-1,” Tissue Antigens, vol. 79, no. 5, pp. 367–371, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. C. L. Davidson, N. L. Li, and D. N. Burshtyn, “LILRB1 polymorphism and surface phenotypes of natural killer cells,” Human Immunology, vol. 71, no. 10, pp. 942–949, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. K. Kuroki, N. Tsuchiya, M. Shiroishi et al., “Extensive polymorphisms of LILRB1 (ILT2, LIR1) and their association with HLA-DRB1 shared epitope negative rheumatoid arthritis,” Human Molecular Genetics, vol. 14, no. 16, pp. 2469–2480, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. S. Kollnberger, A. Chan, M.-Y. Sun et al., “Interaction of HLA-B27 homodimers with KIR3DL1 and KIR3DL2, unlike HLA-B27 heterotrimers, is independent of the sequence of bound peptide,” European Journal of Immunology, vol. 37, no. 5, pp. 1313–1322, 2007. View at Publisher · View at Google Scholar · View at Scopus
  36. F. F. Gonzalez-Galarza, S. Christmas, D. Middleton, and A. R. Jones, “Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations,” Nucleic Acids Research, vol. 39, no. 1, pp. D913–D919, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. J. Robinson, M. J. Waller, P. Stoehr, and S. G. E. Marsh, “IPD—the immuno polymorphism database,” Nucleic Acids Research, vol. 33, supplement 1, pp. D523–D526, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. J. Sidney, B. Peters, N. Frahm, C. Brander, and A. Sette, “HLA class I supertypes: a revised and updated classification,” BMC Immunology, vol. 9, article 1, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. R. Vita, L. Zarebski, J. A. Greenbaum et al., “The immune epitope database 2.0,” Nucleic Acids Research, vol. 38, no. 1, pp. D854–D862, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. E. Krieger, K. Joo, J. Lee et al., “Improving physical realism, stereochemistry, and side-chain accuracy in homology modeling: four approaches that performed well in CASP8,” Proteins, vol. 77, supplement 9, pp. 114–122, 2009. View at Publisher · View at Google Scholar · View at Scopus
  41. E. Krieger, G. Koraimann, and G. Vriend, “Increasing the precision of comparative models with YASARA NOVA—a self-parameterizing force field,” Proteins, vol. 47, no. 3, pp. 393–402, 2002. View at Publisher · View at Google Scholar · View at Scopus
  42. A. P. Graves, D. M. Shivakumar, S. E. Boyce, M. P. Jacobson, D. A. Case, and B. K. Shoichet, “Rescoring docking hit lists for model cavity sites: predictions and experimental testing,” Journal of Molecular Biology, vol. 377, no. 3, pp. 914–934, 2008. View at Publisher · View at Google Scholar · View at Scopus
  43. T. A. Binkowski, S. R. Marino, and A. Joachimiak, “Predicting HLA class I non-permissive amino acid residues substitutions,” PLoS ONE, vol. 7, no. 8, Article ID e41710, 2012. View at Publisher · View at Google Scholar · View at Scopus
  44. B. E. Willcox, L. M. Thomas, and P. J. Bjorkman, “Crystal structure of HLA-A2 bound to LIR-1, a host and viral major histocompatibility complex receptor,” Nature Immunology, vol. 4, no. 9, pp. 913–919, 2003. View at Publisher · View at Google Scholar · View at Scopus
  45. V. Sobolev, E. Eyal, S. Gerzon et al., “SPACE: a suite of tools for protein structure prediction and analysis based on complementarity and environment,” Nucleic Acids Research, vol. 33, no. 2, pp. W39–W43, 2005. View at Publisher · View at Google Scholar · View at Scopus
  46. E. Morel and T. Bellón, “HLA class I molecules regulate IFN-γ production induced in NK cells by target cells, viral products, or immature dendritic cells through the inhibitory receptor ILT2/CD85j,” Journal of Immunology, vol. 181, no. 4, pp. 2368–2381, 2008. View at Publisher · View at Google Scholar · View at Scopus
  47. N. Rapin, I. Hoof, O. Lund, and M. Nielsen, “The MHC motif viewer: a visualization tool for MHC binding motifs,” Current Protocols in Immunology, chapter 18, unit 18.17, 2010. View at Google Scholar
  48. J. E. Gumperz, N. M. Valiante, P. Parham, L. L. Lanier, and D. Tyan, “Heterogeneous phenotypes of expression of the NKB1 natural killer cell class I receptor among individuals of different human histocompatibility leukocyte antigens types appear genetically regulated, but not linked to major histocompatibililty complex haplotype,” Journal of Experimental Medicine, vol. 183, no. 4, pp. 1817–1827, 1996. View at Publisher · View at Google Scholar · View at Scopus
  49. V. Litwin, J. Gumperz, P. Parham, J. H. Phillips, and L. L. Lanier, “NKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules,” The Journal of Experimental Medicine, vol. 180, no. 2, pp. 537–543, 1994. View at Publisher · View at Google Scholar · View at Scopus
  50. M. Peruzzi, N. Wagtmann, and E. O. Long, “A p70 killer cell inhibitory receptor specific for several HLA-B allotypes discriminates among peptides bound to HLA-B2705,” The Journal of Experimental Medicine, vol. 184, no. 4, pp. 1585–1590, 1996. View at Publisher · View at Google Scholar · View at Scopus
  51. M. Lichterfeld and X. G. Yu, “The emerging role of leukocyte immunoglobulin-like receptors (LILRs) in HIV-1 infection,” Journal of Leukocyte Biology, vol. 91, no. 1, pp. 27–33, 2012. View at Publisher · View at Google Scholar · View at Scopus